Global HEOR Economic Modelling Senior Associate
Amgen
Global HEOR Economic Modelling Senior Associate
Amgen
Makes biotech medicines for serious illnesses
The Global HEOR Economic Modeling Senior Associate plays a critical role in supporting Amgen’s global market access and health economics strategy through the development of health economic models. This role will partner closely with team lead and Global HEOR Product Leads to ensure strong alignment with product strategy. The Economic Modeling Senior Associate will develop cost-effectiveness, budget impact, and other health economic models that reflect clinical and real-world data to inform HTA and payer decision-making.
Design and develop hands on global core health economic models for products at all stages of development and launch, using cost-effectiveness/cost-utility (e.g., markov, partitioned survival model), cost minimization, budget impact, and other techniques, as appropriate.
Program models in software such as Excel, R, or Python, ensuring accurate integration of clinical, real-world data, epidemiological, and economic inputs.
Conduct statistical analyses of clinical trial and real-world data to generate inputs including treatment effects, survival extrapolations, resource use, and health utility estimates.
Design and conduct advanced evidence synthesis, including network meta-analyses (NMA) and matching-adjusted indirect comparisons (MAIC), to inform comparative effectiveness.
Implement various types of scenario and sensitivity analyses such as univariate, multivariate, and probabilistic analyses to test model robustness.
Deliverables will include the model structure, programmed model, technical report, user's guide, and presentation files and publications.
Work closely with team lead and HEOR Product Leads to ensure economic models follow product strategy.
Monitor and integrate evolving HTA guidelines, payer requirements, and methodological advancements.
Interpret complex economic findings to technical and non-technical audiences.
Education
Bachelor’s or Master’s degree in health economics, econometry, statistics, biostatistics, mathematics, operations research, engineering or a related field.
Experience
Years of relevant experience in economic modeling in the pharmaceutical, biotech or consulting setting: +3 years for Master’s degree and +5 years for Bachelor’s degree.
Hands-on experience in developing cost-effectiveness, budget impact models, as well as NMA/MAIC.
Experience supporting HTA submissions or payer evidence generation.
Proficiency with modeling and statistical tools such as Excel, R, SAS, or STATA.
Excellent English oral and written communication, with ability to tailor content to different stakeholders.
Strong quantitative and analytical skills with attention to detail.
Strong project management and time-management abilities.
Innovative use of artificial intelligence to boost efficiency.
Effective cross-functional collaboration and interpersonal skills.
Proactive, independent, and detail-oriented approach to problem-solving.
Comfortable working in a global team across time zones and cultures.
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen